 Transient cell activation neonatal induction tolerance MHC class II Mls alloantigens neonatal injection semiallogeneic spleen cells newborn parental mice results induction tolerance corresponding alloantigen alloAg chimerism cell-injected mice state specific tolerance development transient lupus-like autoimmune syndrome study neonatal injection mice spleen cells host major histocompatibility complex MHC class class II class II minor lymphocyte stimulating Mls alloAg state specific tolerance absence alloreactive CTL and/or Th cell responses spleen thymus injected mice mice tolerant MHC class II class II alloAg presence high levels antibodies immune complexes anti-ssDNA autoantibodies tissue lesions mice Ia Ag expression lymphoid spleen cells wk elevated production overexpression Ia Ag treatment mAb Such manifestations cell activation autoimmunity mice cells host MHC class Ag mice Mls Ag transient increase production overexpression Ia Ag features autoimmunity anti-INF-gamma mAb treatment mice tolerant MHC class II class II Mls birth manifestations cell activation presence vivo-activated alloreactive cells spleen thymus injected mice results mice semiallogeneic cells process tolerance induction efficient early postnatal period maturation peripheralization alloreactive cells cell activation alloAg autoimmunity